Index RUT
P/E 51.31
EPS (ttm) 2.04
Insider Own 2.50%
Shs Outstand 58.27M
Perf Week 0.05%
Market Cap 6.10B
Forward P/E 28.20
EPS next Y 3.71
Insider Trans -4.74%
Shs Float 56.82M
Perf Month 0.49%
Income 120.04M
PEG 3.95
EPS next Q 0.82
Inst Own 103.54%
Short Float 4.51%
Perf Quarter 8.93%
Sales 1.32B
P/S 4.61
EPS this Y 11.41%
Inst Trans -1.99%
Short Ratio 6.33
Perf Half Y 26.62%
Book/sh 22.71
P/B 4.61
EPS next Y 10.77%
ROA 5.73%
Short Interest 2.56M
Perf Year 51.81%
Cash/sh 9.01
P/C 11.62
EPS next 5Y 12.98%
ROE 9.40%
52W Range 67.81 - 108.07
Perf YTD 37.90%
Dividend Est. -
P/FCF 34.78
EPS past 5Y 15.74%
ROI 5.63%
52W High -3.08%
Beta 0.84
Dividend TTM -
Quick Ratio 3.82
Sales past 5Y 7.42%
Gross Margin 45.57%
52W Low 54.48%
ATR (14) 2.30
Dividend Ex-Date -
Current Ratio 5.36
EPS Y/Y TTM 18.48%
Oper. Margin 11.81%
RSI (14) 56.91
Volatility 2.37% 2.04%
Employees 6950
Debt/Eq 0.62
Sales Y/Y TTM 8.35%
Profit Margin 9.07%
Recom 1.55
Target Price 112.40
Option/Short Yes / Yes
LT Debt/Eq 0.61
EPS Q/Q 7.95%
Payout 0.00%
Rel Volume 1.03
Prev Close 105.52
Sales Surprise 1.57%
EPS Surprise 7.77%
Sales Q/Q 7.88%
Earnings Oct 30 AMC
Avg Volume 404.56K
Price 104.75
SMA20 0.58%
SMA50 4.67%
SMA200 19.28%
Trades
Volume 416,807
Change -0.73%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-11-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$103 → $120
Jun-28-24 Initiated
Robert W. Baird
Outperform
$96
Apr-11-24 Initiated
CL King
Buy
$88
Feb-07-24 Initiated
BofA Securities
Neutral
$87
Dec-21-23 Upgrade
Canaccord Genuity
Hold → Buy
$100
Dec-20-22 Downgrade
Canaccord Genuity
Buy → Hold
$73 → $72
Jan-05-21 Upgrade
Needham
Hold → Buy
$65
Sep-28-20 Upgrade
Wells Fargo
Underweight → Equal Weight
$42
Feb-25-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Feb-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$43
Dec-12-19 Downgrade
Wells Fargo
Market Perform → Underperform
$26
Sep-24-19 Initiated
Oppenheimer
Outperform
Sep-10-19 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-26-19 Downgrade
Wells Fargo
Outperform → Market Perform
Jul-26-19 Downgrade
Needham
Buy → Hold
Oct-02-18 Reiterated
Needham
Buy
$67 → $73
Aug-07-18 Downgrade
BofA/Merrill
Buy → Underperform
Jul-24-18 Reiterated
Needham
Buy
$54 → $67
Jun-01-18 Reiterated
Needham
Buy
$54
May-18-18 Reiterated
SunTrust
Buy
$55 → $62
Show Previous Ratings
Nov-25-24 09:15AM
Nov-21-24 12:45PM
Nov-08-24 09:15AM
Nov-05-24 12:45PM
Nov-01-24 09:50AM
09:15AM
Loading…
09:15AM
Oct-30-24 08:00PM
06:25PM
05:23PM
(Associated Press Finance)
04:05PM
Oct-29-24 09:06AM
Oct-21-24 12:10PM
Oct-08-24 05:43PM
Sep-18-24 06:00AM
Sep-17-24 12:34PM
09:20AM
Loading…
09:20AM
07:00AM
Sep-16-24 08:30AM
Sep-11-24 09:25AM
Aug-16-24 03:03AM
Aug-02-24 10:55AM
Aug-01-24 07:30PM
05:40PM
04:36PM
(Associated Press Finance)
04:10PM
04:05PM
Jul-03-24 12:23PM
Jul-02-24 08:00AM
04:32AM
Jul-01-24 09:25AM
09:15AM
Loading…
09:15AM
Jun-28-24 07:52AM
Jun-24-24 09:45AM
06:47AM
Jun-21-24 06:53AM
Jun-18-24 10:57AM
09:25AM
Jun-17-24 06:00AM
Jun-11-24 09:50AM
Jun-07-24 09:45AM
May-30-24 11:31AM
May-23-24 09:50AM
May-22-24 12:23PM
12:21PM
May-21-24 09:25AM
May-16-24 04:05PM
May-15-24 04:52PM
04:05PM
12:11PM
May-14-24 11:58AM
09:25AM
May-01-24 12:47PM
11:27AM
10:47AM
(Thomson Reuters StreetEvents)
09:15AM
03:32AM
Apr-30-24 09:55PM
06:30PM
05:38PM
05:30PM
04:38PM
(Associated Press Finance)
04:05PM
Apr-23-24 10:01AM
Apr-10-24 09:33AM
Mar-29-24 11:30AM
Mar-27-24 09:40AM
Mar-20-24 11:28AM
Mar-19-24 09:25AM
Mar-18-24 05:19PM
Mar-08-24 05:00PM
09:40AM
Mar-07-24 10:43AM
Mar-05-24 09:25AM
Mar-01-24 04:32AM
Feb-29-24 11:24AM
11:03AM
07:38AM
(Thomson Reuters StreetEvents)
Feb-28-24 07:00PM
06:15PM
05:21PM
(Associated Press Finance)
04:05PM
04:05PM
Feb-23-24 09:15AM
Feb-21-24 10:00AM
Feb-19-24 08:38AM
Feb-15-24 09:25AM
Jan-31-24 12:10PM
09:50AM
Jan-30-24 09:55AM
Jan-24-24 01:01PM
Jan-23-24 07:19AM
Jan-16-24 04:05PM
Jan-08-24 09:00AM
Jan-03-24 04:05PM
Dec-27-23 05:11AM
Dec-18-23 04:05PM
Dec-15-23 09:50AM
Dec-11-23 10:25AM
Dec-06-23 09:00AM
Dec-04-23 04:05PM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Millner F. Ann Director Nov 15 '24 Option Exercise 50.50 12,500 631,250 44,891 Nov 18 03:59 PM Millner F. Ann Director Nov 15 '24 Sale 101.55 12,500 1,269,375 32,391 Nov 18 03:59 PM F ANN MILLNER Director Nov 15 '24 Proposed Sale 101.55 12,500 1,269,432 Nov 15 04:09 PM Parra Raul Jr. CFO AND TREASURER Nov 07 '24 Option Exercise 37.71 5,361 202,163 21,722 Nov 12 06:00 AM Parra Raul Jr. CFO AND TREASURER Nov 07 '24 Sale 102.18 5,361 547,787 16,361 Nov 12 06:00 AM Peterson Neil CHIEF OPERATING OFFICER Nov 05 '24 Option Exercise 54.40 5,000 272,000 19,819 Nov 07 06:42 PM Peterson Neil CHIEF OPERATING OFFICER Nov 05 '24 Sale 98.00 5,000 490,000 14,819 Nov 07 06:42 PM Parra Raul Jr. CFO AND TREASURER Nov 05 '24 Option Exercise 54.44 34,000 1,851,100 46,007 Nov 07 06:40 PM Parra Raul Jr. CFO AND TREASURER Nov 05 '24 Sale 98.02 29,646 2,905,901 16,361 Nov 07 06:40 PM Parra Raul Jr. Officer Nov 07 '24 Proposed Sale 102.18 5,361 547,781 Nov 07 05:55 PM Peterson Neil Officer Nov 05 '24 Proposed Sale 98.00 5,000 490,013 Nov 05 04:51 PM Parra Raul Jr. Officer Nov 05 '24 Proposed Sale 99.00 29,646 2,934,954 Nov 05 04:49 PM Millner F. Ann Director Jun 28 '24 Option Exercise 50.50 12,500 631,250 44,891 Jul 02 10:14 AM Millner F. Ann Director Jun 28 '24 Sale 85.00 12,500 1,062,500 32,391 Jul 02 10:14 AM Peterson Neil CHIEF OPERATING OFFICER Jun 10 '24 Option Exercise 44.80 7,500 336,000 22,319 Jun 12 01:28 PM Peterson Neil CHIEF OPERATING OFFICER Jun 10 '24 Sale 81.85 7,500 613,845 14,819 Jun 12 01:28 PM Parra Raul Jr. CFO AND TREASURER Mar 12 '24 Sale 73.95 6,480 479,182 12,007 Mar 13 06:36 PM Wright Joseph CHIEF COMMERCIAL OFFICER Mar 07 '24 Option Exercise 28.20 25,000 705,000 67,223 Mar 08 03:40 PM Wright Joseph CHIEF COMMERCIAL OFFICER Mar 07 '24 Sale 75.68 25,000 1,891,925 42,223 Mar 08 03:40 PM Peterson Neil CHIEF OPERATING OFFICER Mar 06 '24 Option Exercise 44.80 7,500 336,000 14,819 Mar 08 10:11 AM Gunderson Thomas James Director Mar 04 '24 Option Exercise 34.40 25,000 860,000 37,414 Mar 05 12:13 PM Gunderson Thomas James Director Mar 04 '24 Sale 76.03 18,157 1,380,513 19,257 Mar 05 12:13 PM Evans Stephen C. Director Mar 04 '24 Sale 76.35 1,000 76,348 7,226 Mar 05 10:13 AM Millner F. Ann Director Jan 22 '24 Option Exercise 34.40 20,000 688,000 49,960 Jan 24 10:49 AM Millner F. Ann Director Jan 22 '24 Sale 80.00 20,000 1,600,000 29,960 Jan 24 10:49 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite